The number of women with gynecologic cancers enrolled in phase 3 trials has fallen by 90 percent, and the number of gynecologic cancer clinical trials has also declined. The Foundation for Women’s Cancer (FWC) is lobbying patients to speak up to government leaders about the inadequate number of clinical trials available to them, and the NCI is responding to the crisis. (